Angelo Zanniti/LinkedIn
Jun 15, 2026, 13:05
Angelo Zanniti: Back from EHA 2026 Congress
Angelo Zanniti, Medical Biotechnologist at CEINGE Official Profile, shared a post on LinkedIn:
“Back from an inspiring few days at the EHA 2026 Congress in Stockholm.
It was a great opportunity to connect with colleagues, share experiences, and discover the latest advances in hematology and molecular diagnostics.
Conferences like these remind us how quickly our field is evolving and how important collaboration is in driving innovation and improving patient care.
Grateful for the experience and looking forward to putting new ideas into practice.”
Stay updated with Hemostasis Today.
-
Nov 3, 2026, 13:37Godfred Oduro: Engaging Young Students in Thalassemia and Sickle Cell Disease Awareness
-
Nov 3, 2026, 13:37Saskia Middeldorp: The Use of LMWH in Women With Pregnancy Complications
-
Nov 3, 2026, 13:31Nita Radhakrishnan: MRI T2 Reveals Hidden Cardiac and Hepatic Iron Overload in Thalassemia
-
Nov 3, 2026, 13:26Chancellor Donald: Bridging Hematology Innovation and Entrepreneurship to Advance Patient Care
-
Nov 3, 2026, 13:21Pete Stibbs: From Scientific Ideas to Clinical Impact
-
Nov 3, 2026, 13:06Backflow-Induced Clot Formation During Red Cell Transfusion – AABB
-
Nov 3, 2026, 12:38Kemal Karaagac: DOACs vs. VKAs in Cerebral Venous Thrombosis
-
Nov 3, 2026, 12:30Pakeeza Arshad: RDW and Bone Marrow Recovery in Hematological Malignancies
-
Nov 3, 2026, 12:21Mohamed Touhid Patel: Combining Microfluidics and SERS for Advanced Blood Analysis